drugset / Trial / NCT02172105
Multiple Rising Inhalative Doses of BI 1744 CL in Healthy Male Volunteers
RandomizedParallel-groupDouble-blindTreatment
Summary
Study to evaluate safety, tolerability, and pharmacokinetics of BI 1744 CL in healthy Japanese male volunteers.
Timeline
- Start
- 2008-01
- Primary completion
- 2008-05
- Completion
- —
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Olodaterol | Small molecule | 5 ug | Inhaled |
| Subject | Olodaterol | Small molecule | 10 ug | Inhaled |
| Subject | Olodaterol | Small molecule | 20 ug | Inhaled |
Indications
No indication recorded.